Background Tumour mutation burden (TMB), defined as the number of somatic mutations per megabase within the sequenced region in the tumour sample, has been used as a …
Y Li, X Wu, P Yang, G Jiang, Y Luo - arXiv preprint arXiv:2203.02794, 2022 - arxiv.org
The recent development of imaging and sequencing technologies enables systematic advances in the clinical study of lung cancer. Meanwhile, the human mind is limited in …
Immune checkpoint blockade (ICB) is a cancer therapy that is based on promoting an antitumour immune response. Tumour mutation burden (TMB) is an effective biomarker for …